Influence of Collateral Circulation on In-Hospital Death From Anterior Acute Myocardial Infarction  by Pérez-Castellano, Nicasio et al.
Influence of Collateral Circulation on In-Hospital Death From
Anterior Acute Myocardial Infarction
NICASIO PE´REZ-CASTELLANO, MD, EULOGIO J. GARCI´A, MD, MANUEL ABEYTUA, MD,
JAVIER SORIANO, MD, JOSE´ A. SERRANO, MD, JAIME ELI´ZAGA, MD, JAVIER BOTAS, MD,
JOSE´ L. LO´PEZ-SENDO´N, MD, FACC, JUAN L. DELCA´N, MD
Madrid, Spain
Objectives. Our purpose was to study whether the in-hospital
prognosis of anterior acute myocardial infarction (AMI) is influ-
enced by preexistent collateral circulation to the infarct-related
artery.
Background. Collateral circulation exerts beneficial influences
on the clinical course after AMI, but demonstration of improved
survival is lacking.
Methods. We studied 238 consecutive patients with anterior
AMI treated by primary angioplasty within the first 6 h of the
onset of symptoms. Fifty-eight patients with basal Thrombolysis
in Myocardial Infarction (TIMI) flow >1 in the infarct-related
artery or with inadequate documentation of collateral circulation
were excluded. Collateral channels to the infarct-related artery
before angioplasty were angiographically assessed, establishing
two groups: 115 patients (64%) without collateral vessels (group
A) and 65 patients (36%) with collateral vessels (group B).
Results. There were no differences in baseline characteristics
between groups A and B, except for the greater prevalence of
previous angina in group B (15% vs. 34%, p 5 0.003). During the
hospital stay, 26 patients (23%) in group A and 5 (8%) in group B
died (p 5 0.01). Cardiogenic shock accounted for 74% of deaths.
Cardiogenic shock developed in 30 patients (26%) in group A and
in 4 (6%) in group B (p 5 0.001). The absence of collateral
circulation appeared to be an independent predictor of in-hospital
death (odds ratio 3.4, 95% confidence interval 1.2 to 9.6, p 5 0.02)
and cardiogenic shock (odds ratio 5.6, 95% confidence interval 1.9
to 17, p 5 0.002).
Conclusions. Preexistent collateral circulation decreases in-
hospital death from anterior AMI by reducing the incidence of
cardiogenic shock.
(J Am Coll Cardiol 1998;31:512–8)
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In recent years, coronary collateral circulation in the setting of
ischemic heart disease and particularly in myocardial infarction
has been subjected to special interest. Some degree of collat-
eral circulation is present at the onset of acute myocardial
infarction (AMI) in nearly 40% of patients (1,2). Several
studies have shown that the residual blood flow carried by
collateral vessels at the time of AMI exerts some beneficial
effects such as reduction in infarct size (3–5), improvement in
residual ejection fraction and other indexes of pump function
(6–8) and prevention of left ventricular aneurysm formation
(9). However, a demonstration of whether collateral circula-
tion improves prognosis after AMI is lacking (10,11).
The purpose of our study was to determine whether the
presence of collateral circulation to the infarct-related artery in
the first hours of coronary occlusion decreases the in-hospital
mortality rate of patients with AMI. To assess angiographically
the existence of collateral circulation early in AMI, when
myocardial necrosis is taking place and theoretically the ben-
efit of collateral circulation could be maximal, we selected
those patients treated by primary percutaneous transluminal
coronary angioplasty (PTCA). Because patients with non-
anterior AMI had less frequently undergone primary PTCA in
our institution, we selected for the present study only patients
with anterior wall AMI to obtain a more homogeneous popu-
lation.
Methods
Study patients. We selected patients who fulfilled all the
following criteria: 1) admission to the hospital because of
suspected anterior wall AMI (continuous ischemic chest pain
lasting .30 min and a minimum of 0.2 mV of ST segment
elevation in two contiguous anterior precordial leads); 2)
diagnostic coronary angiography showing complete occlusion
of the left anterior descending coronary artery (LAD) (Throm-
bolysis in Myocardial Infarction [TIMI] flow grade 0 or 1); 3)
treatment by primary PTCA within the first 6 h of the onset of
symptoms; and 4) left and right coronary angiograms obtained
before the attempted angioplasty of sufficient quality to assess
the filling of the LAD and side branches by collateral circula-
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tion. Patients with AMI secondary to acute or subacute
coronary occlusion after PTCA or coronary artery bypass graft
surgery (CABG) and patients treated by PTCA after failed
thrombolysis (rescue PTCA) were not considered.
Coronary angiography and primary angioplasty. Patients
received 300 mg of aspirin intravenously as soon as possible
unless there was a known allergy. Coronary angiography and
primary PTCA were performed in the first 6 h from the onset
of symptoms of AMI. Left heart catheterization and left
ventriculography were not performed at this time. Once the
femoral artery was catheterized, 10,000 IU of heparin was
administered with additional boluses of 3,000 IU if needed to
achieve an activated clotting time of $350 s. Coronary arte-
riograms were obtained in at least two projections. Intracoro-
nary nitroglycerin was not administered before diagnostic
angiograms were obtained. Flow in the LAD was determined
before and after primary PTCA and graded as described in the
TIMI trial (12). The LAD occlusion was considered proximal
if it was located before the origin of the first well developed
septal branch, distal if it was located after the origin of the
third diagonal branch and mid if located between these limits.
Coronary stenoses were measured by an on-line automatic
edge detection system (Phillips DCI). Angiographic images
were recorded on 35-mm film at 12.5 frames/s. Primary PTCA
was performed with conventional catheter balloon technique.
Stents were used only for suboptimal balloon angioplasty
result. The policy was to perform angioplasty only to the
infarct-related artery, but in exceptional cases additional an-
gioplasty to another vessel was performed because of compro-
mised hemodynamic status. Intraaortic balloon pumping was
used in patients with hemodynamic instability or established
cardiogenic shock. The primary PTCA was considered success-
ful when flow in the infarct-related artery at the end of the
procedure was TIMI grade 2 or 3 and the residual stenosis was
,50%.
Coronary collateral circulation. We analyzed the collateral
circulation to the occluded LAD existent in the first 6 h of AMI
before the angioplasty attempt. It was assessed in coronary
cineangiograms by two experienced coronary angiographers
who had no knowledge of patient data. We excluded from the
present study patients whose angiograms were inadequate for
assessing the collateral circulation to the LAD because the
injection period was too short, filming of the LAD territory in
contralateral injections was incomplete or right coronary an-
giograms were not obtained before angioplasty. Collateral
circulation was graded by using a semiquantitative scale from 0
to 3 (collateral index) depending on the degree of angiographic
opacification of the occluded LAD in the best injection (13):
0 5 no collateral circulation; 1 5 collateral filling of LAD side
branches without visualization of any epicardial segment; 2 5
collateral partial filling of the epicardial segment, and 3 5
collateral filling of the complete epicardial segment. In case of
noncoincidence, the angiographers reached a consensus.
Groups. In the prospective design of this study we decided
to classify the patients into two groups: group A, patients
without angiographic collateral filling of the LAD or side
branches (collateral index 0), and group B, patients with some
angiographic collateral filling of the LAD or side branches
(collateral index 1, 2 or 3).
In-hospital clinical course. Adjunctive medical therapy
followed the standards of the coronary care unit. The primary
objective of this study was to examine in-hospital death.
Secondary objectives were to examine the occurrence of
reinfarction, malignant arrhythmias, mechanical complications
and cardiogenic shock. Reinfarction was defined as the recur-
rence of ischemic chest pain of $30-min duration with ST
segment elevation of $0.1 mV over the previous ST segment in
two contiguous leads and an MB fraction of creatine kinase
(CK-MB) profile consistent with the diagnosis. Malignant
arrhythmias included sustained ventricular tachycardia, ven-
tricular fibrillation or high degree atrioventricular (AV) block.
Mechanical complications included free wall rupture, ventric-
ular septal rupture and severe mitral regurgitation secondary
to papillary muscle rupture. Cardiogenic shock was indicated
by a systolic blood pressure ,90 mm Hg in association with
signs of tissue hypoperfusion (cold extremities, cyanosis, oligu-
ria or altered mental status) not derived from extramyocardial
causes (hypovolemia, arrhythmias, tamponade, drugs).
Statistical analysis. Continuous variables that did not fol-
low a normal distribution according to the Shapiro-Wilk test
such as age, CK-MB peak serum level and residual stenosis,
are expressed as median and the 25th and 75th percentiles.
Time followed a normal distribution and is expressed as mean
6SD. For comparisons of continuous variables between both
groups the Student t test for unpaired observations was used.
Unless otherwise specified, categoric variables are presented in
the text and tables as number and percent of patients. We used
the chi-square test to compare categoric variables between
groups unless expected values were ,5, in which case we used
the Fisher exact test. The association between collateral circu-
lation as a four-grade variable and mortality was analyzed by
using the Mantel-Haenszel test; collateral indexes 2 and 3 were
combined because their expected values were ,5. Multivariate
analyses for mortality and cardiogenic shock were performed
by multiple logistic regression. Odds ratios were expressed
together with 95% confidence intervals. All results were ana-
lyzed by using a two-sided significance level of 0.05, but all p
values , 0.20 are reported. Data analyses were performed by
using the statistical software JMP 3.0.1 from SAS Institute Inc,
1994, and SPSS 4.0 from SPSS Inc, 1990.
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
AV 5 atrioventricular
CABG 5 coronary artery bypass graft surgery
CK-MB 5 creatine kinase, MB fraction
LAD 5 left anterior descending coronary artery
PTCA 5 percutaneous transluminal coronary angioplasty
TIMI 5 Thrombolysis in Myocardial Infarction (trial)
513JACC Vol. 31, No. 3 PE´REZ-CASTELLANO ET AL.
March 1, 1998:512–8 COLLATERAL CIRCULATION IN AMI
Results
Patients and study groups. From July 1991 to September
1996, 238 patients with suspected anterior wall AMI were
treated in our institution by primary PTCA within the first 6 h
from the onset of symptoms. One hundred twenty-seven of
these patients were treated by primary PTCA because they
were enrolled in investigative trials; the majority of them were
randomly selected in a trial comparing PTCA with thrombo-
lytic treatment. These protocols required informed written
consent and were approved by the review committee of our
institution. The remaining patients were selected to be treated
by primary PTCA because they had contraindications to
thrombolytic treatment, cardiogenic shock, a large infarction
or other high risk characteristics. The descriptive data and
clinical in-hospital course of this group are summarized in
Table 1. For the present analysis, we selected 180 of these
patients who fulfilled the criteria just described. The 58
patients who did not fulfill the criteria had left coronary
angiograms showing a patent LAD (25 patients) with TIMI
flow grade $2 (33 patients) or had angiograms inadequate for
assessing the collateral circulation to the LAD, mostly because
right coronary angiography was not performed before angio-
plasty.
Of the 180 patients included, 115 patients (64%, group A)
did not have angiographically visible collateral circulation to
the LAD (collateral index 0). In the remaining 65 patients
(36%, group B), we found some collateral filling of the LAD
(collateral index 1 in 33 patients [18%], index 2 in 23 patients
[13%] and index 3 in 9 patients [5%]).
Baseline characteristics. The baseline clinical characteris-
tics of groups A and B are summarized in Table 2. Significant
differences between groups were not found in age, gender or
prevalence of the main cardiovascular risk factors. However,
group B had a greater prevalence of previous angina than did
group A (22 patients [34%] vs. 17 [15%], p 5 0.003) and a
tendency to a greater prevalence of previous myocardial
infarction (13 patients [20%] vs. 13 [11%], p 5 0.11).
Coronary angiography and primary angioplasty. The
elapsed time between the onset of symptoms suggestive of
AMI and the opening of the LAD was 195 6 86 min in group
A and 211 6 90 min in group B (p 5 NS). The angiographic
findings and the result of primary PTCA in both groups are
presented in Table 3. There were no significant differences
between groups in the number of diseased vessels, although in
group A there was a tendency to present multivessel disease
less frequently (51 patients [44%] vs. 36 [55%], p 5 0.15). The
proximal segment of the LAD was less frequently occluded in
group A than in group B (43 patients [37%] vs. 36 [55%], p 5
0.05). PTCA was considered successful in a similar proportion
of patients from both groups. The proportion of patients who
received stents during PTCA was also similar in both groups
(22 patients [19%] in group A vs. 16 [25%] in group B, p 5
NS). An intraaortic balloon pump was implanted in 25 patients
(22%) in group A and in 13 (20%) in group B (p 5 NS).
In-hospital course and mortality rate. The clinical compli-
cations that occurred in both study groups are shown in Table
4. Of the 31 patients (17%) who died during the hospital stay,
26 (23%) were from group A and 5 (8%) from group B (p 5
0.01). A progressive decrease in the in-hospital mortality rate
was observed with increasing grades of collateral circulation.
The mortality risk in patients without collateral circulation was
2.5 times higher than in patients with collateral index 1 (p 5
0.06) and 3.6 times higher than in patients with collateral index
2 or 3 (p 5 0.03). This linear association was statistically
significant by the Mantel-Haenszel test (p 5 0.01, Fig. 1).
Other factors associated with in-hospital mortality by univari-
ate analyses are presented in Table 5.
The independent effect of collateral circulation on in-
hospital death was confirmed by a multiple logistic regression
analysis. After adjustment for age, previous infarction, diabe-
tes, multivessel disease and PTCA result, the absence of
Table 1. Descriptive Data and In-Hospital Course of the Initial 238
Patients
Age (yr)
Median (25th, 75th percentiles) 65 (55, 71)
Range 35–91
Cardiogenic shock at admission 37 (16%)
Angiographic findings and primary angioplasty
Baseline TIMI flow in LAD
Grades 0 or 1 205 (86%)
Grades 2 or 3* 33 (14%)
Multivessel disease 114 (48%)
Successful primary angioplasty† 214 (90%)
In-hospital clinical course
Reinfarction 10 (4%)
Malignant arrhythmias‡ 36 (15%)
Mechanical complications§ 8 (3%)
Cardiogenic shock 46 (19%)
In-hospital death 39 (16%)
*Patients with a TIMI flow grade 2 or 3 excluded from the study. †TIMI flow
grade $2 and residual stenosis ,50%. ‡Sustained ventricular tachycardia/
fibrillation or high degree atrioventricular block. §All mechanical complications
were free wall ruptures. Data presented are number (%) of patients, unless
otherwise indicated. LAD 5 left anterior descending coronary artery; TIMI 5
Thrombolysis in Myocardial Infarction trial.
Table 2. Baseline Clinical Characteristics of Study Groups
Group A
(n 5 115 [64%])
Group B
(n 5 65 [36%])
p
Value
Age (yr) 64 (53, 71) 64 (57, 70) NS
Female gender 21 (18%) 12 (18%) NS
Hypercholesterolemia 28 (24%) 14 (22%) NS
Hypertension 39 (34%) 29 (45%) 0.15
Cigarette smoking 68 (59%) 40 (62%) NS
Diabetes mellitus 26 (23%) 13 (20%) NS
Previous angina 17 (15%) 22 (34%) 0.003
Previous MI 13 (11%) 13 (20%) 0.11
Out of hospital cardiac arrest 8 (7%) 3 (5%) NS
Data are presented as median (25th, 75th percentiles) or number (%) of
patient group. Group A 5 patients with collateral index 0; Group B 5 patients
with collateral index 1 to 3; MI 5 myocardial infarction.
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collateral circulation remained an independent predictor of
in-hospital death (p 5 0.01). The final model, after excluding
the variables that did not modify the independent weight of
collateral circulation on in-hospital death, is shown in Table 6.
Cardiogenic shock was the most frequent cause of mortal-
ity, accounting for 74% of deaths. Cardiogenic shock devel-
oped more often in patients from group A than in patients
from group B (30 patients [26%] vs. 4 [6%], p 5 0.001). The
timing of shock seemed different in each group: In group A, 24
(80%) of the 30 patients who experienced cardiogenic shock
were already in shock before PTCA, whereas in group B only
2 of 4 patients had shock before PTCA. Multiple logistic
regression analysis proved that the absence of collateral circu-
lation is also an independent determinant of cardiogenic shock
(odds ratio 5.6, 95% confidence interval 1.9 to 17, p 5 0.002)
after adjustment for age and previous infarction. This explains
the higher in-hospital mortality rate of patients without collat-
eral circulation.
Discussion
Collateral circulation to the occluded LAD was identified
by angiography within the first 6 h of symptom onset in 36% of
patients with anterior AMI. This study demonstrates that in
patients with anterior AMI, the presence of operating collat-
eral vessels to the LAD in the initial hours reduces the
in-hospital mortality rate by decreasing the occurrence of
cardiogenic shock. Thus, the absence of collateral circulation
to the infarct-related artery may be considered an adverse risk
factor in the assessment of short-term prognosis after anterior
AMI.
Collateral assessment. It has been established (14–17) that
reperfusion can be achieved quickly and safely by emergency
PTCA. Diagnostic angiography inherent in the primary PTCA
procedure is a valuable opportunity for assessing coronary
collateral circulation in the first hours of AMI. In recent years,
alternative methods of evaluating coronary collateral circula-
tion have been proposed (18–21) on the basis that angiography
lacks sufficient sensitivity. It is certain that angiography cannot
detect collateral vessels ,100 mm in diameter and can miss
some intramyocardial collateral vessels (9). However, it is also
certain that all normal human hearts have, among the territo-
ries of the major coronary arteries, small anastomotic vessels
Figure 1. Linear association between collateral index (CI) and in-
hospital mortality rate (Mantel-Haenszel test, p 5 0.01). *Collateral
indexes 2 and 3 were grouped because their expected values were ,5.
Collateral circulation was index 2 in 23 patients and index 3 in 9
patients; 1 patient from each of these subgroups died.
Table 3. Angiographic Findings and Primary Angioplasty Results
Group A
(n 5 115 [64%])
Group B




1-vessel disease 64 (56%) 29 (45%)
2-vessel disease 34 (30%) 19 (29%)
3-vessel disease 14 (12%) 14 (22%)
LMCA 3 (3%) 3 (5%)
Level of LAD occlusion 0.05
Distal segment 5 (4%) 1 (2%)
Mid-segment 67 (58%) 28 (43%)
Proximal segment 43 (38%) 36 (55%)
TIMI flow in LAD* NS
Baseline NS
Grade 0 101 (88%) 58 (89%)
Grade 1 14 (12%) 7 (11%)
After angioplasty NS
Grade 0 4 (4%) 5 (8%)
Grade 1 9 (8%) 3 (5%)
Grade 2 38 (33%) 15 (23%)
Grade 3 64 (56%) 42 (65%)
Residual stenosis 28% (15%, 35%) 35% (22%, 40%) 0.02
Successful primary
angioplasty†
102 (89%) 57 (88%) NS
*Patients with flow grades 2 and 3 were excluded from the study. †TIMI flow
grade $2 in the infarct-related artery with residual stenosis ,50%. Data are
presented as number (%) of patients or median (25th, 75th percentiles).
LMCA 5 left main coronary artery; other abbreviations as in Table 1.
Table 4. In-Hospital Course
Group A
(n 5 115 [64%])
Group B
(n 5 65 [36%])
p
Value
Peak CK-MB (U/liter) 391 (233, 526) 298 (166, 488) 0.04
Reinfarction 5 (4%) 2 (3%) NS
Malignant arrhythmias*
All patients 24 (21%) 6 (9%) 0.05
Patients with no or mild
pump failure
6 (7%) of 85 6 (10%) of 61 NS
Mechanical
complications†
5 (4%) 2 (3%) NS
Cardiogenic shock
All patients 30 (26%) 4 (6%) 0.001
Before primary
angioplasty
24 (21%) 2 (3%) 0.001
After primary
angioplasty
6 (5%) 2 (3%) NS
Death 26 (23%) 5 (8%) 0.01
*Sustained ventricular tachycardia/fibrillation or high degree atrioventricular
block. †All mechanical complications were free wall ruptures proved at autopsy
or operation. Data are presented as median (25th, 75th percentiles) or number
(%) of patients. CK-MB 5 creatine kinase, MB fraction.
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that range up to 200 mm in diameter (22). Because collateral
vessels that are too small to be visualized angiographically
probably have no clinical impact, we believe that angiography
offers sufficient sensitivity for clinical purposes.
Collateral vessels exhibit vasomotor responses to different
agents. For example, nitroglycerin enhances collateral flow by
marked vasodilation (23), whereas, various substances gener-
ated by platelet aggregation and thrombus formation in the
setting of AMI (e.g., serotonin, thromboxane A2) have been
implicated in the vasoconstriction of small and collateral
vessels of the area at risk (24). Because we did not inject
intracoronary nitroglycerin before performing the diagnostic
angiograms, the collateral circulation documented better re-
flects the spontaneous previous status, without pharmacologic
enhancing.
Previous coronary heart disease. In this study, patients
with angiographically documented collateral vessels to the
occluded LAD (group B) had a greater prevalence of previous
angina. These findings are in accordance with previous works
(25–29). Other studies (25,29) found a higher prevalence of
myocardial infarction and multivessel disease in patients with
collateral circulation. In our study, patients with collateral
vessels only tended to have previous infarction and multivessel
disease more frequently than did patients without collateral
vessels (p 5 NS). The prevailing opinion is that patients with
performed and matured collateral vessels probably have had a
longer, although sometimes silent, course of ischemic disease
(25,26,28). The existence of a severe coronary stenosis, espe-
cially one with .90% diameter narrowing, or intermittent
occlusions over a nonsignificant plaque, such as those in
patients with vasospastic angina, can induce the development
of collateral vessels from surrounding vascular beds that
remain as potential conduits until a new total occlusion occurs
(28). Nevertheless, high interindividual variability seems to
exist for collateral development in response to ischemic stimuli
(30).
Mortality and complications. In our patients with anterior
AMI treated by primary PTCA, the absence of collateral blood
flow to the ischemic myocardium in the early hours of infarc-
tion was a strong independent predictor of cardiogenic shock
and mortality. The benefit of having collateral circulation was
striking, especially as the patients with collateral vessels at the
time of AMI, our group B, had a greater prevalence of some
high risk characteristics, such as occlusion of the LAD in the
proximal segment, multivessel disease and previous infarction.
The presence of only mild degrees of collateral circulation
(Rentrop index 1) might already exert a protective effect. With
respect to other complications, the proportions of reinfarction
and free wall rupture were similar in groups A and B, although
the number of these events was low. Malignant arrhythmias
such as sustained ventricular tachycardia, ventricular fibrilla-
tion or high degree AV block were more frequent in patients
without collateral vessels, although there were no differences
between groups after patients with cardiogenic shock were
excluded.
Several studies (3–5) have demonstrated that collateral
circulation at the time of AMI reduces infarct size, an effect
that might explain, at least in part, how collateral vessels
protect against cardiogenic shock and mortality. In this work,
higher peak CK-MB levels were observed in patients without
collateral circulation, but this finding has to be cautiously
interpreted given the recognized limitations of CK-MB mea-
surements in estimating infarct size (31–33), especially in
patients with collateral circulation (34).





Age* — — 1.05 (1.01–1.09) 0.01
Female† 27% 15% 2.1 (0.8–5.1) 0.09
Diabetes mellitus 36% 12% 4.1 (1.8–9.4) 0.001
Cigarette smoking† 11% 26% 0.4 (0.2–0.8) 0.01
Proximal LAD occlusion‡ 24% 12% 2.4 (1.1–5.3) 0.03
Collateral circulation to LAD§ 8% 23% 0.3 (0.1–0.7) 0.01
Multivessel disease 25% 10% 3.2 (1.4–7.7) 0.01
Successful primary angioplasty\ 13% 48% 0.2 (0.1–0.5) 0.001
*OR (95% CI) per year of increase. Age (median; 25th, 75th percentiles) of survivors was 63 (53, 70) versus 69 (62,
73) years in nonsurvivors (p 5 0.01). †Association lost after adjustment for age. ‡Versus mid or distal occlusion. §Present
if collateral index $1, absent if collateral index 5 0. \Thrombolysis in Myocardial Infarction flow grade $2 with residual
stenosis ,50% at the end of the procedure. Data indicate mortality rate (%) of patients with the factor present (Yes)
versus absent (No), the odds ratio (OR) with 95% confidence interval (CI) for death if the factor is present and the
significance level (p value). The mortality rate was not different in patients with (19%) or without (17%) previous
infarction. LAD 5 left anterior descending coronary artery.




Age (OR/yr of increase) 1.05 (1.01–1.09) 0.01
Previous infarction 1.3 (0.4–3.8) NS
Collateral circulation absent† 3.4 (1.2–9.6) 0.02
*Multiple logistic regression. †Collateral index 5 0. Abbreviations as in
Table 5.
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When total arterial flow is reduced by coronary stenosis or
occlusion, coronary vasodilator reserve is exceeded and flow to
the ischemic region is distributed along a gradient that is
inversely related to the gradient of intramyocardial pressure.
Therefore, the small amounts of blood flow provided through
the collateral route are distributed in a nonuniform pattern,
being preferentially shunted to the subepicardial zone where
intramyocardial pressure is lowest (35). In experimental mod-
els, nearly transmural infarcts develop in dogs with very little
collateral flow, whereas nontransmural infarcts, with survival
of myocardium in the subepicardial zone (36,37), develop in
dogs with substantial collateral flow, which is always greatest in
this zone. The lower incidence of cardiogenic shock in patients
with collateral vessels could be explained, at least in part, by
the preservation of an epicardial rim of viable myocardium
when operating collateral vessels are present at the time of
infarction. This phenomenon could ameliorate the systolic
dysfunction and promote a partial functional recovery of the
involved wall segment early after AMI. This mechanism could
also explain the observation of others (9,38) of a low incidence
of infarct expansion and aneurysm formation in patients with
well developed collateral channels at the time of infarction.
Limitations of the study. The population origin of the
present study is a partly selected high risk group. Although the
majority of patients were treated by primary PTCA in an
unselected manner because of their participation in investiga-
tive trials, many patients in this study were selected to undergo
primary PTCA because they had high risk characteristics,
especially cardiogenic shock or extensive infarction. For this
reason the rates of adverse events of the study population,
particularly cardiogenic shock and death, are increased; con-
sequently, the relative importance of collateral circulation in
reducing cardiogenic shock and mortality might be less striking
in unselected populations.
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